163 related articles for article (PubMed ID: 37988030)
1. Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.
Zhou T; Wang HW; Ng SB; Summers T; Xi L; Raffeld M; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2024 Apr; 48(4):426-436. PubMed ID: 37988030
[TBL] [Abstract][Full Text] [Related]
2. Eosinophil-rich variant of nodal marginal zone lymphoma: a clinicopathological study of 11 cases.
Miyake M; Sakata S; Tsuyama N; Togashi Y; Noguchi M; Tsukada N; Kumagai T; Mishima Y; Takeuchi K
Histopathology; 2023 Sep; 83(3):443-452. PubMed ID: 37222201
[TBL] [Abstract][Full Text] [Related]
3. Primary nodal marginal zone lymphomas of splenic and MALT type.
Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
[TBL] [Abstract][Full Text] [Related]
4. MYD88 L265P mutation analysis helps define nodal lymphoplasmacytic lymphoma.
Hamadeh F; MacNamara SP; Aguilera NS; Swerdlow SH; Cook JR
Mod Pathol; 2015 Apr; 28(4):564-74. PubMed ID: 25216226
[TBL] [Abstract][Full Text] [Related]
5. [Abnormal expression of bcl-10 protein in extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue lymphoma type].
Li BZ; Zhou XY; Ye HT; Yang WT; Fan YZ; Lu HF; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2007 Dec; 36(12):819-24. PubMed ID: 18346354
[TBL] [Abstract][Full Text] [Related]
6. Expansion of PD1-positive T Cells in Nodal Marginal Zone Lymphoma: A Potential Diagnostic Pitfall.
Egan C; Laurent C; Alejo JC; Pileri S; Campo E; Swerdlow SH; Piris M; Chan WC; Warnke R; Gascoyne RD; Xi L; Raffeld M; Pittaluga S; Jaffe ES
Am J Surg Pathol; 2020 May; 44(5):657-664. PubMed ID: 31764221
[TBL] [Abstract][Full Text] [Related]
7. [Nodal marginal zone B-cell lymphoma: a clinicopathologic study of 10 cases].
Zhang YN; Zhou XG; Zhang SH; Zheng YY; Liu WH
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):529-33. PubMed ID: 17980100
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
9. Identification of MNDA as a new marker for nodal marginal zone lymphoma.
Kanellis G; Roncador G; Arribas A; Mollejo M; Montes-Moreno S; Maestre L; Campos-Martin Y; Ríos Gonzalez JL; Martinez-Torrecuadrada JL; Sanchez-Verde L; Pajares R; Cigudosa JC; Martin MC; Piris MA
Leukemia; 2009 Oct; 23(10):1847-57. PubMed ID: 19474799
[TBL] [Abstract][Full Text] [Related]
10. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
[TBL] [Abstract][Full Text] [Related]
12. Indolent lymphomas in the pediatric population: follicular lymphoma, IRF4/MUM1+ lymphoma, nodal marginal zone lymphoma and chronic lymphocytic leukemia.
Quintanilla-Martinez L; Sander B; Chan JK; Xerri L; Ott G; Campo E; Swerdlow SH
Virchows Arch; 2016 Feb; 468(2):141-57. PubMed ID: 26416032
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of the novel marginal zone B-cell marker IRTA1 in malignant lymphoma.
Ikeda JI; Kohara M; Tsuruta Y; Nojima S; Tahara S; Ohshima K; Kurashige M; Wada N; Morii E
Hum Pathol; 2017 Jan; 59():70-79. PubMed ID: 27666766
[TBL] [Abstract][Full Text] [Related]
14. Nodal reactive and neoplastic proliferation of monocytoid and marginal zone B cells: an immunoarchitectural and molecular study highlighting the relevance of IRTA1 and T-bet as positive markers.
Bob R; Falini B; Marafioti T; Paterson JC; Pileri S; Stein H
Histopathology; 2013 Oct; 63(4):482-98. PubMed ID: 23855758
[TBL] [Abstract][Full Text] [Related]
15. The many faces of nodal and splenic marginal zone lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Zamò A; van den Brand M; Climent F; de Leval L; Dirnhofer S; Leoncini L; Ng SB; Ondrejka SL; Quintanilla-Martinez L; Soma L; Wotherspoon A
Virchows Arch; 2023 Sep; 483(3):317-331. PubMed ID: 37656249
[TBL] [Abstract][Full Text] [Related]
16. Partial nodal involvement by marginal zone lymphoma. Use of IGK gene rearrangement analysis in diagnostic work-up.
Gazzola A; Sabattini E; Mannu C; Bacci F; Sagramoso Sacchetti CA; Artioli P; Chilli L; Da Pozzo G; Piccioli M; Falini B; Pileri SA; Piccaluga PP
Pathologica; 2011 Feb; 103(1):14-8. PubMed ID: 21837920
[TBL] [Abstract][Full Text] [Related]
17. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
[TBL] [Abstract][Full Text] [Related]
18. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
[TBL] [Abstract][Full Text] [Related]
19. A subset of low-grade B cell lymphomas with a follicular growth pattern but without a
van den Brand M; Balagué O; van Cleef PH; Groenen PJ; Hebeda KM; de Jong D; van Krieken JH
J Hematop; 2016 Mar; 9(1):3-8. PubMed ID: 26949422
[TBL] [Abstract][Full Text] [Related]
20. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas.
Tandon B; Peterson L; Gao J; Nelson B; Ma S; Rosen S; Chen YH
Mod Pathol; 2011 Nov; 24(11):1433-43. PubMed ID: 21685909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
